Skip to content

Assessment of Investigational Magnetic Resonance Imaging and Post-Processing Procedures

Assessment of Investigational Magnetic Resonance Imaging and Post-Processing Procedures

Status
Active, not recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03490656
Enrollment
77
Registered
2018-04-06
Start date
2016-10-21
Completion date
2024-12-31
Last updated
2024-01-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

MRI Imaging

Brief summary

The goals of this study are to (1) develop and optimize MRI acquisition and post-processing techniques and (2) to generate preliminary and comparative data on sequences for potential clinical trials.

Detailed description

This prospective study will utilize investigational MRI sequences both in a volunteer population as well as in patients in addition to standard of care MR imaging to develop and optimize MRI sequence post-processing techniques as well as to generate preliminary and comparative data for potential clinical trials. These post-processing techniques include but are not limited to visual inspection of image quality and known anatomy, semi-quantitative analysis including the use of rating schemes, signal-to-noise-ratios and contrast-to-noise-ratios measurements for quantitative assessment, standard fitting procedures for measuring MRI parameters, and using various published methods for image post-processing. The MRI methodologies we plan to use as part of this study will allow us to obtain morphological, functional and molecular information. For the patient population: Patients receiving a standard of care 1.5 or 3T MRI will be asked by study personnel if they are interested in undergoing additional investigational imaging sequences after their standard of care imaging. If the patient agrees, he/she will remain in the same position on the MRI scanner for up to an additional 30 minutes while more images are obtained. Each patient will be imaged for no longer than 2 hours (standard of care imaging and additional investigational imaging). A routine clinical report will be generated for the clinically indicated MRI by a radiologist. Once this routine clinical MRI scan is dictated and finalized, a study team member will obtain the report via IHIS and manually remove all identifiers. This report is being obtained for comparative purposes. All the data being compared will be coded using a unique study number. For the volunteer population: Healthy volunteers recruited through the OSU Wexner Medical Center or accompanying patients to their standard of care imaging appointments at The Wright Center of Innovation will be asked by study personnel if they are interested in undergoing investigational MR imaging sequences. If the volunteer agrees, he/she will be imaged on the MRI scanner for up to 60 minutes while images are obtained. Other than the participant signing the informed consent form, no participant information or protected health information (PHI) will be recorded. Following the informed consent authorization, the participant's name will be coded using a unique study number.

Interventions

DIAGNOSTIC_TESTMRI Scan - in addition to standard of care

Up to 3 Tesla (T) MRI

DIAGNOSTIC_TESTMRI Scan - not in addition to standard of care

Up to 3 Tesla (T) MRI

Sponsors

University of Cincinnati
Lead SponsorOTHER

Study design

Allocation
NON_RANDOMIZED
Intervention model
SINGLE_GROUP
Primary purpose
DIAGNOSTIC
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* Male and female volunteers greater than or equal to 18 years of age * Patients receiving a standard of care 1.5 or 3T MRI at The Ohio State University * Healthy volunteers that feel comfortable receiving an investigational mRI

Exclusion criteria

* Participants with a contraindication to MRI. Such contraindications include, but are not limited to: pacemaker, metallic cardiac valve(s), magnetic material such as surgical clips, tattoos, implanted electronic infusion pumps or any other condition that would interfere with the MRI, a stent somewhere, a history of allergic reaction to any metals * Participants that experience claustrophobia, anxiety and/or vertigo when moved inside the scanner * Participants with vital signs outside of normal range * Prisoners * Subjects incapable of giving informed written consent * Participants who are pregnant, healthy volunteers

Design outcomes

Primary

MeasureTime frameDescription
Image qualitythrough study completion, an average of 1-3 yearsassessed by blinded readers
Artifactsthrough study completion, an average of 1-3 yearsassessed by blinded readers
Lesion detectabilitythrough study completion, an average of 1-3 yearsassessed by blinded readers
Image noisethrough study completion, an average of 1-3 yearsassessed region of interest over target tissue and background

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026